Abstract: An electric compressor, wherein an oil separator is formed on an inner wall on the discharge path, and wherein the oil separator is formed in a concavo-convex shape along a rotation direction of the refrigerant on the discharge path. In the compressor, the farther it is from a discharge hole along a rotation direction of the refrigerant, the greater the depth of a first groove portion formed in an oil separator is. As a result, the oil contained in the refrigerant is separated.

Abstract: A battery module includes a cell holder including insertion regions in which battery cells arranged in a plurality of columns are inserted, and a blocking part which covers an insertion region of the insertion regions in which a battery cell is not inserted.

Abstract: The present invention relates to a novel compound as a protein kinase inhibitor, in particular, a RON inhibitor.

Abstract: The present invention relates to a pharmaceutical composition containing ?-lapachone as an active ingredient for prevention or treatment of cholestatic liver disease, and can provide agents for effectively preventing and treating cholestatic liver disease.

Abstract: The present invention relates to a novel compound as a protein kinase inhibitor, particularly, a RON inhibitor.

Abstract: The present invention relates to a novel compound as a protein kinase inhibitor, a RON inhibitor in particular.

Abstract: The present invention relates to a novel compound as a protein kinase inhibitor, a RON inhibitor in particular.

Abstract: An electric compressor, wherein an oil separator is formed on an inner wall on the discharge path, and wherein the oil separator is formed in a concavo-convex shape along a rotation direction of the refrigerant on the discharge path. In the compressor, the farther it is from a discharge hole along a rotation direction of the refrigerant, the greater the depth of a first groove portion formed in an oil separator is. As a result, the oil contained in the refrigerant is separated.

Abstract: The present invention relates to a pharmaceutical composition containing ?-lapachone as an active ingredient for prevention or treatment of cholestatic liver disease, and can provide agents for effectively preventing and treating cholestatic liver disease.

Abstract: The present invention provides a shackle, which includes: a shackle body formed in a bar shape bent so that opposite ends are adjacent to each other and face the same direction as each other, wherein the shackle body passes through a through hole formed in a loop at an end of a linear wire body; fastening rings provided at opposite ends of the shackle body, respectively, and having a penetration hole formed therein, wherein at least one of the fastening rings is detachably coupled to the shackle body; a first fastening means which passes through the penetration hole of the fastening ring to prevent the linear wire body from being separated from the shackle in a fastened state; and a second fastening means which is coupled with the first fastening means to prevent the linear wire body from being separated from the shackle together with the first fastening means.

Abstract: A substrate processing apparatus includes: a disk including a plurality of electrostatic chucks periodically disposed at a constant radius from a central axis; a disk support supporting the disk; a DC line electrically connected to the plurality of electrostatic chucks through the disk support; and a power supply configured to supply power to the DC line. The DC line includes: a first DC line penetrating through the disk support from the power supply; a power distribution unit configured to distribute the first DC line to connect the first DC line to each of the plurality of electrostatic chucks; and a plurality of second DC lines respectively connected to the plurality of electrostatic chucks in the power distribution unit.

Abstract: The present invention relates to a pharmaceutical composition containing ?-lapachone as an active ingredient for prevention or treatment of cholestatic liver disease, and can provide agents for effectively preventing and treating cholestatic liver disease.

Abstract: A substrate processing apparatus includes: a disk including a plurality of electrostatic chucks periodically disposed at a constant radius from a central axis; a disk support supporting the disk; a DC line electrically connected to the plurality of electrostatic chucks through the disk support; and a power supply configured to supply power to the DC line. The DC line includes: a first DC line penetrating through the disk support from the power supply; a power distribution unit configured to distribute the first DC line to connect the first DC line to each of the plurality of electrostatic chucks; and a plurality of second DC lines respectively connected to the plurality of electrostatic chucks in the power distribution unit.

Abstract: The present invention relates to a pharmaceutical composition containing (?-lapachone as an active ingredient for prevention or treatment of cholestatic liver disease, and can provide agents for effectively preventing and treating cholestatic liver disease.

Abstract: A substrate processing apparatus includes: a disk including a plurality of electrostatic chucks periodically disposed at a constant radius from a central axis; a disk support supporting the disk; a DC line electrically connected to the plurality of electrostatic chucks through the disk support; and a power supply configured to supply power to the DC line. The DC line includes: a first DC line penetrating through the disk support from the power supply; a power distribution unit configured to distribute the first DC line to connect the first DC line to each of the plurality of electrostatic chucks; and a plurality of second DC lines respectively connected to the plurality of electrostatic chucks in the power distribution unit.

Abstract: The present disclosure relates to a dwarfism animal model carrying an IGF-1 gene mutation and a method for generating the same. According to the present disclosure, the problem that an animal dies immediately after birth is overcome, the majority of phenotypes seen in Laron syndrome patients may be observed in the dwarfism animal model, and the dwarfism animal model has decreased expression of personality genes. Thus, the dwarfism animal model may be effectively used as a dwarfism-related disease model.

Abstract: A substrate processing apparatus includes: a disk including a plurality of electrostatic chucks periodically disposed at a constant radius from a central axis; a disk support supporting the disk; a DC line electrically connected to the plurality of electrostatic chucks through the disk support; and a power supply configured to supply power to the DC line. The DC line includes: a first DC line penetrating through the disk support from the power supply; a power distribution unit configured to distribute the first DC line to connect the first DC line to each of the plurality of electrostatic chucks; and a plurality of second DC lines respectively connected to the plurality of electrostatic chucks in the power distribution unit.

Abstract: A flight control operation of a reference aerial vehicle is performed. For example, an image captured by an image sensor of the reference aerial vehicle is received. A target is detected in the image. A three-dimensional relative location of the target with respect to the reference aerial vehicle is determined based on the image. The flight control operation is performed based on the three-dimensional relative location of the target with respect to the reference aerial vehicle.

Abstract: The present inventive concept relates to a substrate processing apparatus and a gas distribution apparatus for substrate processing apparatuses including: a plasma generator generating plasma for performing a processing process on a substrate supported by a substrate supporting unit; a ground body coupled to the plasma generator; and a plasma shield shielding the plasma generated by the plasma generator, wherein the plasma generator includes a first electrode for generating the plasma and a second electrode coupled to the ground body at a position spaced apart from the first electrode so that a gas distribution space for distributing a process gas is provided between the first electrode and the second electrode, and the plasma shield shields the plasma, generated by the plasma generator, in at least one of a top of the substrate and a bottom of the substrate.

Abstract: A flight control operation of a reference aerial vehicle is performed. For example, an image captured by an image sensor of the reference aerial vehicle is received. A target is detected in the image. A three-dimensional relative location of the target with respect to the reference aerial vehicle is determined based on the image. The flight control operation is performed based on the three-dimensional relative location of the target with respect to the reference aerial vehicle.